TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 393 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,865,000 | -2.0% | 156,897 | -2.3% | 0.21% | -7.8% |
| Q4 2020 | $2,923,000 | -4.3% | 160,586 | -6.2% | 0.23% | -16.4% |
| Q3 2020 | $3,054,000 | -1.4% | 171,202 | -0.9% | 0.28% | -1.8% |
| Q2 2020 | $3,097,000 | +13.7% | 172,715 | -3.8% | 0.28% | +1.4% |
| Q1 2020 | $2,724,000 | -26.4% | 179,464 | -4.3% | 0.28% | +47.6% |
| Q4 2019 | $3,701,000 | +75.7% | 187,565 | +53.2% | 0.19% | +107.8% |
| Q3 2019 | $2,106,000 | -12.9% | 122,440 | -10.3% | 0.09% | -7.2% |
| Q2 2019 | $2,417,000 | +13.4% | 136,544 | +30.4% | 0.10% | +16.9% |
| Q1 2019 | $2,132,000 | – | 104,672 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |